Cognitive and Psychological Disorders After Severe COVID-19 Infection

NCT04937582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-02-09

No results posted yet for this study

Summary

As COVID-19 pandemic is still ongoing, patients follow-up begins to reveal cognitive and psychological disorders. There are not yet well described, neither their physiopathology. This study will consist in the detection and characterization of cognitive and psychological impairments in young patients under 65 years of age who have been hospitalized more than 72 hours for a severe COVID-19 infection.

Conditions

  • COVID 19

Interventions

DIAGNOSTIC_TEST

Cognitive assessment

Complete cognitive and psychological assessment

DIAGNOSTIC_TEST

Imaging

Brain MRI Optional: Brain FDG PET (Brain positron emission tomography with F-18 fluorodeoxyglucose)

DIAGNOSTIC_TEST

Routine care

Electroencephalogram (EEG) Optional: polysomnography, lumbar puncture

OTHER

Psychiatric evaluation

Psychiatric consultation if necessary

OTHER

Psychiatric evaluation

Psychiatric consultation if necessary (before the end of their participation in the study)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER
  • University Hospital, Strasbourg, France

    collaborator OTHER
  • Centre Hospitalier Régional Metz-Thionville

    collaborator OTHER
  • Centre hospitalier Epinal

    collaborator UNKNOWN
  • Hopitaux Civils de Colmar

    collaborator OTHER
  • Central Hospital, Nancy, France

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2023-09-27
Completion
2023-09-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937582 on ClinicalTrials.gov